IL6 and cancer: The observation that the risk of cancer-related mortality and lung metastasis is higher in SARS-CoV-2-infected patients and the demonstration that IL-6 associated with SARS-CoV2 infection can awaken dormant breast carcinoma cells metastasized in the lung of mice support this possibility [175].